-
-
-
-
-
-
-
FDA grants priority review to AstraZeneca's efzimfotase alfa for bone disease
-
-
-
-
-
-
-
Scholar Rock (SRRK) PT Raised to $70 at H.C. Wainwright
-
-
-
-
-
-
-
FDA accepts review of application to extend Miudella IUD use to 6 years
-
-
-
-
-
-
-
Belite Bio, Inc, ADR (BLTE) PT Raised to $245 at H.C. Wainwright
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)
-
-
-
-
-
-
-
BioXcel Therapeutics files for Chapter 11, agrees to sell assets to Teva
-
-
-
-
-
-
-
AnaptysBio (ANAB) PT Lowered to $70 at TD Cowen
-
15,818 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

